130 related articles for article (PubMed ID: 15316362)
1. Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.
Bethge WA; Wilbur DS; Storb R; Hamlin DK; Santos EB; Brechbiel MW; Sandmaier BM
Transplantation; 2004 Aug; 78(3):352-9. PubMed ID: 15316362
[TBL] [Abstract][Full Text] [Related]
2. Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.
Bethge WA; Wilbur DS; Storb R; Hamlin DK; Santos EB; Brechbiel MW; Fisher DR; Sandmaier BM
Blood; 2003 Jun; 101(12):5068-75. PubMed ID: 12609833
[TBL] [Abstract][Full Text] [Related]
3. Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
Sandmaier BM; Bethge WA; Wilbur DS; Hamlin DK; Santos EB; Brechbiel MW; Fisher DR; Storb R
Blood; 2002 Jul; 100(1):318-26. PubMed ID: 12070043
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation.
Nakamae H; Kerbauy FR; Wilbur DS; Bethge W; Hamlin DK; Santos EB; Storb R; Sandmaier BM
Transplantation; 2010 Jun; 89(11):1336-40. PubMed ID: 20351629
[TBL] [Abstract][Full Text] [Related]
5. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
Chen Y; Kornblit B; Hamlin DK; Sale GE; Santos EB; Wilbur DS; Storer BE; Storb R; Sandmaier BM
Blood; 2012 Feb; 119(5):1130-8. PubMed ID: 22134165
[TBL] [Abstract][Full Text] [Related]
6. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
[TBL] [Abstract][Full Text] [Related]
7. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
Barsoukov AA; Moore PF; Storb R; Santos EB; Sandmaier BM
Transplantation; 1999 May; 67(10):1329-35. PubMed ID: 10360586
[TBL] [Abstract][Full Text] [Related]
8. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
Sandmaier BM; Fukuda T; Gooley T; Yu C; Santos EB; Storb R
Exp Hematol; 2003 Feb; 31(2):168-75. PubMed ID: 12591282
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
Bethge WA; Wilbur DS; Sandmaier BM
Leuk Lymphoma; 2006 Jul; 47(7):1205-14. PubMed ID: 16923548
[TBL] [Abstract][Full Text] [Related]
10. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
11. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
[TBL] [Abstract][Full Text] [Related]
12. Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
Nakamae H; Wilbur DS; Hamlin DK; Thakar MS; Santos EB; Fisher DR; Kenoyer AL; Pagel JM; Press OW; Storb R; Sandmaier BM
Cancer Res; 2009 Mar; 69(6):2408-15. PubMed ID: 19244101
[TBL] [Abstract][Full Text] [Related]
13. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
Jochum C; Beste M; Zellmer E; Graves SS; Storb R
Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
[TBL] [Abstract][Full Text] [Related]
14. Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation.
Kornblit B; Chen Y; Sandmaier BM
Chimerism; 2012; 3(2):40-2. PubMed ID: 22772070
[TBL] [Abstract][Full Text] [Related]
15. Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization".
Nakaya A; Qiu H; Santos EB; Hamlin DK; Wilbur DS; Storb R; Sandmaier BM
Transplant Cell Ther; 2021 Jun; 27(6):476.e1-476.e7. PubMed ID: 33775618
[TBL] [Abstract][Full Text] [Related]
16. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
[TBL] [Abstract][Full Text] [Related]
17. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.
Panse JP; Storb R; Storer B; Santos EB; Wentzel C; Sandmaier BM
Transplantation; 2005 Nov; 80(10):1518-21. PubMed ID: 16340800
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
[TBL] [Abstract][Full Text] [Related]
20. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
